The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis
Clinical trial NCT05186922 · UNKNOWN
Trial details
- NCT number
- NCT05186922
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-17
- Primary completion
- 2023-01-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.